Most Viewed Articles
Articles | Fulltext downloads | PDF downloads | Total downloads |
---|---|---|---|
EditorialIndian Journal of Skin Allergy – Embracing new horizonsFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_39_2023 |
1,352 | 85,828 | 87,180 |
Review ArticleReactive and proactive treatment in atopic dermatitis: Long-term disease controlFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_31_2023 |
3,099 | 83,498 | 86,597 |
CommentaryStatus of research and publication in IndiaFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_29_2023 |
2,336 | 73,542 | 75,878 |
EditorialEczema and skin allergy-focus on researchFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_29_2024 |
1,393 | 60,478 | 61,871 |
Case ReportHair depigmentation in a patient treated with pazopanib: A case report and a comprehensive analysisFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_52_2023 |
3,012 | 44,164 | 47,176 |
Original ArticleEfficacy and safety of crisaborole ointment in pediatric atopic dermatitis: A 4-week open-label studyFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_45_2023 |
2,827 | 40,110 | 42,937 |
Letter to EditorMethotrexate in refractory chronic urticariaFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_15_2024 |
2,022 | 38,831 | 40,853 |
Case ReportAmbroxol-induced leukocytoclastic vasculitis: A case report and literature reviewFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_37_2023 |
2,333 | 37,097 | 39,430 |
Review ArticleCutaneous adverse drug reactions in children with a focus on hypersensitivity to systemic drugs: A narrative reviewFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_14_2024 |
1,305 | 35,341 | 36,646 |
Original ArticleComorbidities in patients with chronic urticaria: A cross sectional study from an Urticaria Center of Reference and ExcellenceFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_26_2023 |
3,407 | 24,518 | 27,925 |
SymposiumInvestigations and treatment of photodermatosesFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_6_2024 |
1,904 | 20,969 | 22,873 |
Case ReportA novel pitch against the itchFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_13_2024 |
2,742 | 18,845 | 21,587 |
Case ReportPembrolizumab-induced resolving papulosquamous eruption: An enigmatic presentation in a patient with renal cell carcinomaFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_3_2024 |
2,391 | 18,667 | 21,058 |
Review ArticlePigmented contact dermatitis: An updated reviewFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_44_2023 |
4,905 | 14,164 | 19,069 |
ImageGiant fixed drug eruptionFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_47_2023 |
2,281 | 13,970 | 16,251 |
Letter to EditorPost-herpetic neuralgia-associated patchy hair loss closely mimicking trichotillomaniaFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_19_2024 |
1,819 | 13,490 | 15,309 |
SymposiumPhototoxicity and photoallergy – A brief review on pathogenesis, recent advances, and approach to a patient with photosensitivityFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_9_2024 |
2,678 | 10,821 | 13,499 |
Original ArticleThe effectiveness of bilastine and fexofenadine updosing in the management of chronic spontaneous urticariaFull text![]() ![]() ![]() Year: 2022, Volume: 1, Issue: 2, July-December DOI: 10.25259/IJSA_3_2021 |
10,788 | 2,341 | 13,129 |
Letter to EditorDasatinib-induced hand foot syndrome followed by bosutinib-induced photoallergic contact dermatitis in a patient of chronic myeloid leukemia: A rare co-occurrenceFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_1_2024 |
1,690 | 11,352 | 13,042 |
Letter to EditorHomemade lip injection for cosmetic purpose: A case reportFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_42_2023 |
1,534 | 11,329 | 12,863 |
SymposiumCutaneous photobiologyFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_11_2024 |
2,413 | 9,044 | 11,457 |
Letter to EditorCutaneous vasculitis as the sole clinical feature of primary Sjögren’s syndromeFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_48_2023 |
2,430 | 8,873 | 11,303 |
Review ArticleA review of comorbidities in atopic dermatitisFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_37_2024 |
3,296 | 7,445 | 10,741 |
Original ArticleStudy of effectiveness of methotrexate oral pulse in refractory chronic urticariaFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_28_2023 |
2,246 | 8,444 | 10,690 |
Case ReportPenile angioedema in a child: A nightmare to parents!Full text![]() ![]() ![]() Year: 2022, Volume: 1, Issue: 1, January-June DOI: 10.25259/IJSA_5_2021 |
8,570 | 2,073 | 10,643 |
Resident’s CornerAllergic reactions to radiocontrast media–A brief overviewFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_4_2024 |
1,887 | 8,674 | 10,561 |
Letter to EditorHeat urticaria – Characterizing the population from an urticaria center of reference and excellence (UCARE)Full text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_51_2023 |
2,536 | 7,643 | 10,179 |
SymposiumPolymorphous light eruptionsFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_8_2024 |
1,831 | 8,224 | 10,055 |
Letter to EditorHot car seat thermal burn: A must sought for differential diagnosis in summersFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_31_2024 |
1,322 | 8,683 | 10,005 |
Original ArticleImpact of atopic dermatitis on quality of life in children and their families: A tertiary care hospital-based study from Northern IndiaFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_5_2024 |
2,645 | 7,296 | 9,941 |
Case ReportSubacute cutaneous lupus erythematosus in a patient of pancreatic cancer secondary to novel albumin-bound paclitaxel chemotherapyFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_25_2023 |
1,639 | 8,051 | 9,690 |
Review ArticleStem-cell therapy in dermatology – Challenges and opportunitiesFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_50_2023 |
3,752 | 5,928 | 9,680 |
Original ArticlePatch testing with Indian standard series of 20 allergens in 125 patients of chronic dermatitis and dermatosesFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_16_2024 |
3,702 | 5,880 | 9,582 |
CommentaryFellowship and mentorship opportunities in allergic skin disorders for Indian dermatologistsFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_30_2023 |
1,837 | 7,421 | 9,258 |
Original ArticleAtopic dermatitis in teenagers and adults: Clinical features of a tertiary referral hospitalFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_21_2022 |
1,657 | 7,232 | 8,889 |
SymposiumChronic actinic dermatitisFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_10_2024 |
1,905 | 6,793 | 8,698 |
Review ArticleJAK inhibitors in dermatologyFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_7_2021 |
6,255 | 2,243 | 8,498 |
Letter to EditorTeledermatology trends during two waves of the COVID-19 pandemic – Experience from western RajasthanFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_21_2024 |
1,381 | 7,105 | 8,486 |
Author’s replyPembrolizumab-induced resolving papulosquamous eruption: An enigmatic presentation in a patient with renal cell carcinomaFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_41_2024 |
1,369 | 6,994 | 8,363 |
Letter to EditorAre dermatologists a well-informed audience for artificial intelligence? A knowledge, attitude, and practice surveyFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_20_2024 |
1,623 | 4,832 | 6,455 |
Case ReportA rare case of diffuse penile phytocontact dermatitis caused by common greenbrierFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_22_2022 |
3,358 | 2,430 | 5,788 |
Case SeriesHand eczema associated with frequent hand washing and use of hand sanitizer during COVID-19 pandemic: A case seriesFull text![]() ![]() ![]() Year: 2022, Volume: 1, Issue: 2, July-December DOI: 10.25259/IJSA_11_2021 |
3,405 | 1,948 | 5,353 |
Review ArticleBiomarkers of chronic spontaneous urticariaFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_14_2023 |
3,639 | 1,624 | 5,263 |
Review ArticleChronic inducible urticaria: Clinical presentation, diagnosis, and managementFull text![]() ![]() ![]() Year: 2022, Volume: 1, Issue: 1, January-June DOI: 10.25259/IJSA_12_2021 |
3,550 | 1,521 | 5,071 |
Review ArticleDigital object identifier: What it is and why it matters?Full text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_20_2023 |
3,470 | 1,212 | 4,682 |
Letter to EditorVitamin D levels in patients with chronic spontaneous urticariaFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_3_2023 |
2,857 | 1,717 | 4,574 |
Letter to EditorSymmetrical drug-related intertriginous and flexural exanthema without baboon syndrome due to paracetamol: An uncommon side effect of a common drug: A case report and a review of literatureFull text![]() ![]() ![]() Year: 2024, Volume: 3, Issue: 2, July-December DOI: 10.25259/IJSA_30_2024 |
1,200 | 3,262 | 4,462 |
Letter to EditorComparative real-world clinical assessment of mometasone furoate 0.1% and fluticasone propionate 0.005% in the treatment of atopic dermatitisFull text![]() ![]() ![]() Year: 2022, Volume: 1, Issue: 2, July-December DOI: 10.25259/IJSA_4_2022 |
2,923 | 1,473 | 4,396 |
Letter to EditorExosome therapy in atopic dermatitis – A way to look forwardFull text![]() ![]() ![]() Year: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_26_2022 |
2,167 | 2,184 | 4,351 |
Letter to EditorInducible urticaria or skin lesions induced by Nd: YAG laser?Full text![]() ![]() ![]() Year: 2025, Volume: 4, Issue: 1, January-June DOI: 10.25259/IJSA_41_2023 |
1,448 | 2,898 | 4,346 |